跳至主要内容
临床试验/NCT01694914
NCT01694914已完成3 期

Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium

Centre Hospitalier Universitaire de Saint Etienne4 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2012年1月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
122
试验地点
4
主要终点
the primary outcome is the endothelial cell density (ECD) of the corneal grafts.

研究概览

简要总结

At present, all commercially available corneal organ culture media contain foetal calf serum (FCS) and sometimes other compounds extracted from animals. These compounds are necessary for corneal cell survival but are problematic because they theoretically have risk of anthropozoonosis transmission, especially for new variant of CJD and the variability between FCS batches influence graft quality. Our laboratory research allowed in vitro and ex vivo validation of a new medium free compound animal. We proved its superiority over conventional medium containing 2% FCS for endothelial cell survival during the storage time. The goal of this clinical trial is now to assess its superiority in patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male and female patients
  • •over 18 years of age
  • •Clinically proven corneal disease
  • •Registered on the French National waiting list (GLAC)
  • •Patient informed consent
  • •Patient who needs a 8.25mm of diameter perforating keratoplasty, either isolated or combined with lens surgery
  • •Low immune rejection risk (< 2 quadrants of neovascularization, no previous history of herpetic keratitis nor graft rejection)
  • •No previous history of glaucoma or elevated intra ocular pressure (>22 mm

排除标准

  • •Patient is unlikely to comply with the requirements of the protocol

研究组 & 干预措施

organ culture medium containing 2% of fœtal calf serum

Active Comparator

Patients in this arm receive a corneal graft stored in organ culture in a commercial organ culture medium containing 2% of fœtal calf serum

干预措施: corneal graft (Procedure)

Animal Compound Free Medium

Experimental

Patients in this arm receive a corneal graft stored in organ culture in a animal compound free medium

干预措施: corneal graft (Procedure)

结局指标

主要结局

the primary outcome is the endothelial cell density (ECD) of the corneal grafts.

时间窗: one year after graft

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验